Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.

Colwell, C W; Berkowitz, S D; Davidson, B L; Lotke, P A; Ginsberg, J S; Lieberman, J R; Neubauer, J; McElhattan, J L; Peters, G R; Francis, C W

Colwell, C W; Berkowitz, S D; Davidson, B L; Lotke, P A; Ginsberg, J S; Lieberman, J R; Neubauer, J; McElhattan, J L; Peters, G R; Francis, C W.

Affiliation

Colwell CW; Scripps Clinic Center for Orthopaedic Research and Education, 11025 North Torrey Pines Road, Suite 140, La Jolla, CA 92037-1030, USA. colwell@scripps.edu

J Thromb Haemost ; 1(10): 2119-30, 2003 Oct.

Article in En | MEDLINE | ID: mdl-14521593

Subject(s)

Azetidines/pharmacology; Enoxaparin/pharmacology; Thrombin/antagonists & inhibitors; Thromboembolism/prevention & control; Administration, Oral; Aged; Anticoagulants/pharmacology; Arthroplasty, Replacement, Hip; Benzylamines; Double-Blind Method; Female; Hemorrhage; Hemostatics/pharmacology; Humans; Male; Middle Aged; Prodrugs/pharmacology; Random Allocation; Venous Thrombosis/prevention & control; Wound Healing/drug effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Azetidines / Thromboembolism / Thrombin / Enoxaparin Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Thromb Haemost Year: 2003 Document type: Article

Search on Google

XML

PubMed Links